Risk Factor Analysis for Instability after Systemic-pulmonary Shunt |
Jung Sung-Ho
(Department of Thoracic and Cardiovascular Surgery, College of Medicine, University of Ulsan)
Yun Sok-Won (Department of Thoracic and Cardiovascular Surgery, College of Medicine, University of Ulsan) Park Jung-Jun (Department of Thoracic and Cardiovascular Surgery, College of Medicine, University of Ulsan) Seo Dong-Man (Department of Thoracic and Cardiovascular Surgery, College of Medicine, University of Ulsan) Kim Young-Hwue (Department of Pediatrics, College of Medicine, University of Ulsan) Ko Jae-Kon (Department of Pediatrics, College of Medicine, University of Ulsan) Park In-Sook (Department of Pediatrics, College of Medicine, University of Ulsan) Yun Tae-Jin (Department of Thoracic and Cardiovascular Surgery, College of Medicine, University of Ulsan) |
1 | Lunn RJ. Inhaled nitric oxide therapy. Mayo Clin Proc 1995: 70:247-55 DOI PUBMED ScienceOn |
2 | Tworetzky W, Moore P, Bekker JM, Bristow J, Black SM, Fineman JR. Pulmonary blood flow alters nitric oxide production in patients undergoing device closure of atrial septal defects. J Am Coli Cardiol 2000;35:463-7 DOI ScienceOn |
3 | Komai H, Adatia IT, Elliott MJ, de Leval MR, Haworth SQ. Increased plasma levels of endothelin-l after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 1993; 106:473-8 |
4 | Roberts jr JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitirc oxide in congenital heart disease. Circulation 1993;87:447-53 DOI ScienceOn |
5 | Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991;181:852-7 DOI ScienceOn |
6 | Downing SW, Edmunds LH. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 1992; 54:1236-43 DOI ScienceOn |
7 | Quillen JE, Selke FW, Brooks LA, Harrison DG.lschemiareperjusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 1990;82:586-94 DOI ScienceOn |
8 | Beyersdorf F, Matheis G, Kruger S, et al. Avoiding reperjusion injury after limb revascularization: experimental observation and recommendations for clinical application. J Vase Surg 1989;9:757-66 DOI |
9 | Laitinen PO, Rasanen J, Sairanen H. Postoperative nitric oxide therapy in children with congenital heart disease. Can the need be predicted? Scand Cardiovasc J 2000;34:149-53 DOI |
10 | Berner M, Beghetti M, Spahr-Schopfer I, Oberhansli I, Friedli B. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease. Am J Cardiol 1994;77:532-5 DOI ScienceOn |
11 | Summers ST, Zinner MJ, Freischlag JA. Production of Endothelium-derived relaxing facur (EDRF) is compromised after ischemia and reperjusion. Am J Surg 1993;166:216-20 DOI ScienceOn |
12 | Journais D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations fir congenital heart defects. J Thorac Cardiovasc Surg 1994;107:1129-35 |
13 | Yahagi N, Kumon K, Tanigami H, et al. Cardiac surgery and inhaled nitric oxide: indication and follow-up (2-4 years). Artif Organs 1998;22:886-891 DOI ScienceOn |
14 | Shah AS, Smerling AJ, Quaegebeur JM, Michler RE. Nitric oxide treatment for pulmonary hypertension after neonatal cardiac operation. Ann Thorac Surg 1995;60:1791-3 DOI ScienceOn |
15 | McIntyre RC Jr, harken AH, Fullerton DA. Mechanisms of pulmonary vasomotor junction in normal and injured lung. Surgery 1994;115:273-5 |
16 | Miller OI, Celerrneyer DS, Deanfield JE, Macrae DJ. Very low dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenitla heart disease. J Thorae Cardiovasc Surg 1994;108:487-94 |
17 | Alkhulaifi AM, Gayet FL, Serraf A, Belli E, Planche C. Systemic pulmonary shunt in reo nates: early clinical outcome and choice of surgical approach. Ann Thorac Surg 2000;69:1499-504 DOI ScienceOn |
18 | Rocchini AP, Rosenthal A, Barger AC, Casteneda AR, Nadas AS. Pathogenesis of paradoxiacla hypertension after coarctation resection. Circulation 1976;54:382-7 DOI ScienceOn |
19 | Fullerton DA, Jones SD, Jaggers J, Piedalue F, Grover FL, McIntyre FC. Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac surgery. J Thorae Cardiovasc Surg 1996;111:753-63 DOI ScienceOn |
20 | Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing nitirc oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991:83: 2038-47 DOI ScienceOn |
21 | Trolin G, Anden T, Hedenstiema G. Nitric oxide (NO) in expired air at rest and during exercise. Acta Physiol Scand 1994;151:159-63 DOI ScienceOn |
22 | McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-63 DOI PUBMED ScienceOn |
23 | Ku DD. Coronary vascular reactidty after acute myocardial ischemia. Science 1982;218:576-8 DOI PUBMED |
24 | Matsui J, Yahagi N, Kumon K, et al. Effect of inhaled nitric oxide on postoperative pulmonay circulation in patients with congenital heart disease. Artif Organs 1997;21:17-20 DOI ScienceOn |
25 | Beghetti M, Morris K, Cox P, Bohn D, Adatia I. Inhaled nitric oxide differetiates pulmonary vasospasm from vascular obstruction after surgery for congenital heart disease. Intensive Care Med 1999;25:1126-30 DOI ScienceOn |
26 | Adatia I, Atz AM, Jonas RA. Wessel DL. Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. J Thorac Cardiovasc Surg 1996;112:1403-5 DOI ScienceOn |
27 | Ferreiro CR, Chagas AC, Carvalho MH, et al. Influence of hypoxia on nitric oxide synthase activity and gene expression in children with congenital heart disese: a novel pathophysiological adaptive mechanism. Circulation 2001;103:2272-6 DOI ScienceOn |